CN105496801A - 一种包覆维生素a棕榈酸酯的纳米固体脂质载体及其制备方法 - Google Patents
一种包覆维生素a棕榈酸酯的纳米固体脂质载体及其制备方法 Download PDFInfo
- Publication number
- CN105496801A CN105496801A CN201610033759.9A CN201610033759A CN105496801A CN 105496801 A CN105496801 A CN 105496801A CN 201610033759 A CN201610033759 A CN 201610033759A CN 105496801 A CN105496801 A CN 105496801A
- Authority
- CN
- China
- Prior art keywords
- palmitate
- oil
- vitamin
- peg
- solid lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 title claims abstract description 174
- 239000007787 solid Substances 0.000 title claims abstract description 120
- 150000002632 lipids Chemical class 0.000 title claims abstract description 118
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 title claims abstract description 87
- 229940108325 retinyl palmitate Drugs 0.000 title claims abstract description 87
- 235000019172 retinyl palmitate Nutrition 0.000 title claims abstract description 87
- 239000011769 retinyl palmitate Substances 0.000 title claims abstract description 87
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000011248 coating agent Substances 0.000 title claims description 15
- 238000000576 coating method Methods 0.000 title claims description 15
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 40
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 28
- 239000007788 liquid Substances 0.000 claims abstract description 24
- 239000003755 preservative agent Substances 0.000 claims abstract description 22
- 230000002335 preservative effect Effects 0.000 claims abstract description 18
- 229910017053 inorganic salt Inorganic materials 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000003756 stirring Methods 0.000 claims abstract description 9
- 239000008367 deionised water Substances 0.000 claims abstract description 8
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 8
- 150000003839 salts Chemical class 0.000 claims abstract description 6
- 229930182478 glucoside Natural products 0.000 claims description 24
- -1 PEG-8 distearate Chemical compound 0.000 claims description 20
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 18
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical class COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 18
- 239000003921 oil Substances 0.000 claims description 18
- 235000019198 oils Nutrition 0.000 claims description 18
- 239000002994 raw material Substances 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 15
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 14
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 14
- 150000008131 glucosides Chemical class 0.000 claims description 14
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 14
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 12
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 12
- 239000012071 phase Substances 0.000 claims description 12
- 229940083466 soybean lecithin Drugs 0.000 claims description 12
- 239000004359 castor oil Substances 0.000 claims description 10
- 235000019438 castor oil Nutrition 0.000 claims description 10
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 claims description 10
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 10
- 150000001298 alcohols Chemical class 0.000 claims description 9
- 229960000541 cetyl alcohol Drugs 0.000 claims description 9
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 9
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 8
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 8
- 229960002216 methylparaben Drugs 0.000 claims description 8
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 claims description 7
- 229960001083 diazolidinylurea Drugs 0.000 claims description 7
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 7
- 239000001103 potassium chloride Substances 0.000 claims description 7
- 235000011164 potassium chloride Nutrition 0.000 claims description 7
- GKAVWWCJCPVMNR-UHFFFAOYSA-N tridecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCC GKAVWWCJCPVMNR-UHFFFAOYSA-N 0.000 claims description 7
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 claims description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 6
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 claims description 6
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 6
- WREAKAFXVZGTPL-UHFFFAOYSA-N OCC1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O.OCC1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O.C(C(C)O)O Chemical compound OCC1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O.OCC1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O.C(C(C)O)O WREAKAFXVZGTPL-UHFFFAOYSA-N 0.000 claims description 6
- 235000021314 Palmitic acid Nutrition 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 239000001110 calcium chloride Substances 0.000 claims description 6
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 6
- 229940074979 cetyl palmitate Drugs 0.000 claims description 6
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosanyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 claims description 6
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 claims description 6
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims description 6
- 229940078812 myristyl myristate Drugs 0.000 claims description 6
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 6
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 claims description 6
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical class CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 claims description 5
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 claims description 5
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 5
- 235000021357 Behenic acid Nutrition 0.000 claims description 5
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 241000726221 Gemma Species 0.000 claims description 5
- 235000018330 Macadamia integrifolia Nutrition 0.000 claims description 5
- 240000000912 Macadamia tetraphylla Species 0.000 claims description 5
- 235000003800 Macadamia tetraphylla Nutrition 0.000 claims description 5
- NKSOSPOXQKNIKJ-CLFAGFIQSA-N Polyoxyethylene dioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOC(=O)CCCCCCC\C=C/CCCCCCCC NKSOSPOXQKNIKJ-CLFAGFIQSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 229940116226 behenic acid Drugs 0.000 claims description 5
- 229940073669 ceteareth 20 Drugs 0.000 claims description 5
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 claims description 5
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 5
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 5
- 239000010466 nut oil Substances 0.000 claims description 5
- 229940032052 peg-8 dioleate Drugs 0.000 claims description 5
- 229940043707 polyglyceryl-6 distearate Drugs 0.000 claims description 5
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 5
- 239000008158 vegetable oil Substances 0.000 claims description 5
- 239000001993 wax Substances 0.000 claims description 5
- 239000010497 wheat germ oil Substances 0.000 claims description 5
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 claims description 4
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 claims description 4
- RHXUZFJBEKLEPQ-UHFFFAOYSA-N 5-bromo-5-nitro-1,3-dioxane propane-1,2-diol Chemical compound CC(O)CO.[O-][N+](=O)C1(Br)COCOC1 RHXUZFJBEKLEPQ-UHFFFAOYSA-N 0.000 claims description 4
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 claims description 4
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- 239000008346 aqueous phase Substances 0.000 claims description 4
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 4
- 229960000735 docosanol Drugs 0.000 claims description 4
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 claims description 4
- 125000005456 glyceride group Chemical group 0.000 claims description 4
- 229940075529 glyceryl stearate Drugs 0.000 claims description 4
- 229940070765 laurate Drugs 0.000 claims description 4
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 claims description 4
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 claims description 4
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 4
- 150000003431 steroids Chemical class 0.000 claims description 4
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 claims description 4
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 claims description 4
- 229940012831 stearyl alcohol Drugs 0.000 claims description 3
- 150000003445 sucroses Chemical class 0.000 claims description 3
- 150000003626 triacylglycerols Chemical class 0.000 claims description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 claims description 2
- ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 claims description 2
- KPOYDLLPVNBIGV-UHFFFAOYSA-N 1-phenyl-3-(2,3,4-trichlorophenyl)urea Chemical compound ClC1=C(Cl)C(Cl)=CC=C1NC(=O)NC1=CC=CC=C1 KPOYDLLPVNBIGV-UHFFFAOYSA-N 0.000 claims description 2
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 claims description 2
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 claims description 2
- ILCOCZBHMDEIAI-UHFFFAOYSA-N 2-(2-octadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCO ILCOCZBHMDEIAI-UHFFFAOYSA-N 0.000 claims description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical class CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 claims description 2
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 claims description 2
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 claims description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 2
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 claims description 2
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 claims description 2
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 claims description 2
- VPPHKHDARGZSFK-UHFFFAOYSA-N 5,5-bis(hydroxymethyl)imidazolidine-2,4-dione Chemical compound OCC1(CO)NC(=O)NC1=O VPPHKHDARGZSFK-UHFFFAOYSA-N 0.000 claims description 2
- AMUTYVGRCVFCCD-UHFFFAOYSA-N 5,6-diaminopyridine-3-carboxylic acid Chemical compound NC1=CC(C(O)=O)=CN=C1N AMUTYVGRCVFCCD-UHFFFAOYSA-N 0.000 claims description 2
- 244000144725 Amygdalus communis Species 0.000 claims description 2
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 2
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 2
- 239000004287 Dehydroacetic acid Substances 0.000 claims description 2
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 claims description 2
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 claims description 2
- 235000019774 Rice Bran oil Nutrition 0.000 claims description 2
- 235000019485 Safflower oil Nutrition 0.000 claims description 2
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- FSEJJKIPRNUIFL-UHFFFAOYSA-N [2,2-bis(hydroxymethyl)-3-octadecanoyloxypropyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CO)(CO)COC(=O)CCCCCCCCCCCCCCCCC FSEJJKIPRNUIFL-UHFFFAOYSA-N 0.000 claims description 2
- QTIMEBJTEBWHOB-PMDAXIHYSA-N [3-[(z)-octadec-9-enoyl]oxy-2,2-bis[[(z)-octadec-9-enoyl]oxymethyl]propyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COC(=O)CCCCCCC\C=C/CCCCCCCC)(COC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC QTIMEBJTEBWHOB-PMDAXIHYSA-N 0.000 claims description 2
- SMLXTTLNOGQHHB-UHFFFAOYSA-N [3-docosanoyloxy-2,2-bis(docosanoyloxymethyl)propyl] docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC SMLXTTLNOGQHHB-UHFFFAOYSA-N 0.000 claims description 2
- OCKWAZCWKSMKNC-UHFFFAOYSA-N [3-octadecanoyloxy-2,2-bis(octadecanoyloxymethyl)propyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC OCKWAZCWKSMKNC-UHFFFAOYSA-N 0.000 claims description 2
- CFRNDJFRRKMHTL-UHFFFAOYSA-N [3-octanoyloxy-2,2-bis(octanoyloxymethyl)propyl] octanoate Chemical compound CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)(COC(=O)CCCCCCC)COC(=O)CCCCCCC CFRNDJFRRKMHTL-UHFFFAOYSA-N 0.000 claims description 2
- 239000008168 almond oil Substances 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims description 2
- 235000021302 avocado oil Nutrition 0.000 claims description 2
- 239000008163 avocado oil Substances 0.000 claims description 2
- 235000013871 bee wax Nutrition 0.000 claims description 2
- 239000012166 beeswax Substances 0.000 claims description 2
- 229940092738 beeswax Drugs 0.000 claims description 2
- DMSMPAJRVJJAGA-UHFFFAOYSA-N benzo[d]isothiazol-3-one Chemical compound C1=CC=C2C(=O)NSC2=C1 DMSMPAJRVJJAGA-UHFFFAOYSA-N 0.000 claims description 2
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 claims description 2
- 229940067596 butylparaben Drugs 0.000 claims description 2
- 229940073639 ceteareth-6 Drugs 0.000 claims description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 2
- 235000012000 cholesterol Nutrition 0.000 claims description 2
- 229940080421 coco glucoside Drugs 0.000 claims description 2
- 239000003240 coconut oil Substances 0.000 claims description 2
- 235000019864 coconut oil Nutrition 0.000 claims description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 claims description 2
- 235000019258 dehydroacetic acid Nutrition 0.000 claims description 2
- 229940061632 dehydroacetic acid Drugs 0.000 claims description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 claims description 2
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 claims description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 2
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 claims description 2
- 229940093471 ethyl oleate Drugs 0.000 claims description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 2
- 125000005908 glyceryl ester group Chemical group 0.000 claims description 2
- 239000008169 grapeseed oil Substances 0.000 claims description 2
- 239000004519 grease Substances 0.000 claims description 2
- XAMHKORMKJIEFW-AYTKPMRMSA-N hexadecyl (z,12r)-12-hydroxyoctadec-9-enoate Chemical class CCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC XAMHKORMKJIEFW-AYTKPMRMSA-N 0.000 claims description 2
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 229940100554 isononyl isononanoate Drugs 0.000 claims description 2
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 claims description 2
- 229940093629 isopropyl isostearate Drugs 0.000 claims description 2
- 229940119170 jojoba wax Drugs 0.000 claims description 2
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 claims description 2
- 229940095102 methyl benzoate Drugs 0.000 claims description 2
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 claims description 2
- 235000010755 mineral Nutrition 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 235000010446 mineral oil Nutrition 0.000 claims description 2
- 239000002480 mineral oil Substances 0.000 claims description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 2
- KHLCTMQBMINUNT-UHFFFAOYSA-N octadecane-1,12-diol Chemical compound CCCCCCC(O)CCCCCCCCCCCO KHLCTMQBMINUNT-UHFFFAOYSA-N 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 claims description 2
- 229960002446 octanoic acid Drugs 0.000 claims description 2
- 229940049964 oleate Drugs 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- 229940032067 peg-20 stearate Drugs 0.000 claims description 2
- 229940119519 peg-32 stearate Drugs 0.000 claims description 2
- 229940032051 peg-8 distearate Drugs 0.000 claims description 2
- 229960005323 phenoxyethanol Drugs 0.000 claims description 2
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 claims description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 2
- 229960003415 propylparaben Drugs 0.000 claims description 2
- 239000008165 rice bran oil Substances 0.000 claims description 2
- 235000005713 safflower oil Nutrition 0.000 claims description 2
- 239000003813 safflower oil Substances 0.000 claims description 2
- LWBVAHQZGAKXPU-BOXHHOBZSA-M sodium;(4s)-4-amino-5-octadecoxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOC(=O)[C@@H](N)CCC([O-])=O LWBVAHQZGAKXPU-BOXHHOBZSA-M 0.000 claims description 2
- 235000010199 sorbic acid Nutrition 0.000 claims description 2
- 239000004334 sorbic acid Substances 0.000 claims description 2
- 229940075582 sorbic acid Drugs 0.000 claims description 2
- 229940032094 squalane Drugs 0.000 claims description 2
- 229940098760 steareth-2 Drugs 0.000 claims description 2
- 229940100458 steareth-21 Drugs 0.000 claims description 2
- 229940080728 steareth-30 Drugs 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 235000020238 sunflower seed Nutrition 0.000 claims description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 2
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N trilaurin Chemical compound CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000013877 carbamide Nutrition 0.000 claims 1
- 229960001777 castor oil Drugs 0.000 claims 1
- 235000019197 fats Nutrition 0.000 claims 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims 1
- 235000019871 vegetable fat Nutrition 0.000 claims 1
- 230000035515 penetration Effects 0.000 abstract description 8
- 238000001816 cooling Methods 0.000 abstract description 2
- 238000002525 ultrasonication Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 11
- 239000000047 product Substances 0.000 description 8
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
- 230000035699 permeability Effects 0.000 description 6
- 235000019155 vitamin A Nutrition 0.000 description 6
- 239000011719 vitamin A Substances 0.000 description 6
- 229940045997 vitamin a Drugs 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 239000002502 liposome Substances 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 239000012736 aqueous medium Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- FBNAWLJSQORPAX-UHFFFAOYSA-N 4-methyl-3-propan-2-ylphenol Chemical compound CC(C)C1=CC(O)=CC=C1C FBNAWLJSQORPAX-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
一种包覆维生素A棕榈酸酯的纳米固体脂质载体及制备方法,所述包覆维生素A棕榈酸酯的纳米固体脂质载体按重量百分比计算由1~15%维生素A棕榈酸酯、0.5~5%磷脂、3~30%固态乳化剂、2~15%固体脂质、2~10%液体脂质、0.02~1%无机盐、0.01~0.8%防腐剂和余量去离子水组成。其制备方法即将维生素A棕榈酸酯、磷脂、固态乳化剂、固体脂质及液态脂质熔融并分散均匀得油相,将无机盐、去离子水混合加热得到水相,搅拌下加入油相,依次经超声、冷却后加防腐剂,得包覆维生素A棕榈酸酯的纳米固体脂质载体。即通过纳米固体脂质载体提高了维生素A棕榈酸酯的稳定性和分散性,促进维生素A棕榈酸酯在皮肤上的渗透。
Description
技术领域
本发明涉及一种包覆维生素A棕榈酸酯的纳米固体脂质载体及其制备方法,属于化工领域。
背景技术
天然功效成分维生素A棕榈酸酯是维生素A和棕榈酸酯化后的产物。其具备了维生素的功能,可以用于体外皮肤病的治疗,如牛皮廯、痤疮、光老化和上皮癌等。与天然维生素A相比,相对提高了稳定性。但是酯化后仍容易被破坏,不溶于水、乙醇等,对空气、光和湿度敏感,熔点为28~29℃。因此用于制剂时不稳定,容易在储存和使用过程中变质。同时,具有一定的刺激性,如可引发红廯、剥落脱皮和见光后的灼烧感。往往通过乳化、包覆等技术促使其更好的分散。
纳米固体脂质载体(NLC),是固体油脂在冷却或相分离过程中固化和结晶形成的固体微粒。作为一种新型的载体,纳米固体脂质载体具备生理相容性好、可生物降解、载药能力强、物理化学存储稳定、成本低、利于大规模生产等优点。作用于化妆品中,可以增强活性成分的渗透性、提高闭合作用和水合作用,同时作为包覆载体可以提高活性成分的稳定性。
目前关于包覆维生素A棕榈酸酯技术,有用明胶形成的纤维膜包覆维生素A(CN104846555A);也有用阿拉伯胶形成的微胶囊结构包覆维生素A(CN104661656A);而微胶囊结构在一定的剪切力下,结构很容易破坏,不适合应用于化妆品产品体系中。而包覆维生素A的纳米固体脂质载体目前尚未见报道。
发明内容
本发明目的之一是为了解决上述的维生素A棕榈酸酯应用于化妆品中不稳定、分散性能差,在皮肤上不易渗透等技术问题而提供一种包覆维生素A棕榈酸酯的纳米固体脂质载体。该包覆维生素A棕榈酸酯的纳米固体脂质载体使得维生素A棕榈酸酯稳定,在水介质中分散性能好,同时有利于在皮肤上的渗透等优点。
本发明的目的之二在于提供上述一种包覆维生素A棕榈酸酯的纳米固体脂质载体的制备方法。
本发明的技术方案
一种包覆维生素A棕榈酸酯的纳米固体脂质载体,按重量百分比计算,其原料组成及含量如下:
所述的磷脂为磷脂酰胆碱(以下简称PC)含量为50%~95%的大豆卵磷脂、蛋黄卵磷脂、氢化卵磷脂中的一种或两种以上的组合;优选为磷脂酰胆碱含量为50%-90%的大豆卵磷脂、磷脂酰胆碱含量为70%的蛋黄卵磷脂或磷脂酰胆碱含量为95%的氢化卵磷脂;
所述的固态乳化剂为鲸蜡硬脂醇聚醚类、PEG酯类、葡糖苷类、聚甘油-3甲基葡糖二硬脂酸酯、硬酯酰谷氨酸钠、双子星乳化剂或聚甘油-6双硬脂酸酯;
其中硬脂醇聚醚类为鲸蜡硬脂醇聚醚-25、鲸蜡硬脂醇聚醚-6、鲸蜡硬脂醇聚醚-12、鲸蜡硬脂醇聚醚-20、鲸蜡硬脂醇聚醚-30、硬脂醇聚醚-2、硬脂醇聚醚-21或三鲸蜡硬酯醇醚-4磷酸;
PEG酯类为PEG-20三山嵛酸甘油酯、PEG-8双油酸酯、PEG-8双硬脂酸酯、PEG-4月桂酸酯、PEG-8油酸酯、PEG-8硬脂酸酯、PEG-8蜂蜡、PEG-20硬脂酸酯或PEG-32硬脂酸酯、PEG-40氢化蓖麻油、PEG-20十八醇醚、PEG-15十六十八醇醚、PEG-2十六醇醚、PEG-10十六醇醚或PEG-4月桂酸酯;
葡糖苷类为鲸蜡硬脂基葡糖苷、羟基硬脂醇与羟基硬脂糖苷、蔗糖酯、花生醇葡糖苷、山嵛醇葡糖苷、鲸蜡硬脂基葡糖苷、鲸蜡硬脂醇葡糖苷、椰油基葡糖苷、PEG-20甲基葡萄糖苷倍半硬脂酸酯或甲基葡萄糖苷倍半硬脂酸酯;
所述的固体脂质为饱和脂肪酸类、类固醇类、甘油酯类、蜡质类、醇类、氢化蓖麻油、鲸蜡硬酯醇、硬酯醇或季戊四醇二硬脂酸酯;
其中饱和脂肪酸类为硬脂酸、棕榈酸、癸酸或二十二酸
类固醇类为胆固醇;
甘油酯类为硬脂酸甘油酯、鲸蜡硬酯醇辛酸酯、单硬脂酸甘油酯、棕榈酸鲸蜡酯、三硬脂酸甘油酯或三月桂酸甘油酯;
蜡质类为季戊四醇四山俞酸酯、季戊四醇四辛酸/癸酸酯、季戊四醇四油酸酯、季戊四醇四硬脂酸酯、肉豆蔻酸十四烷酯、乳酸鲸蜡酯、蓖麻油酸鲸蜡酯、肉豆蔻酸肉豆蔻酯、棕榈酸十六酯、十八酸十八酯、鲸蜡醇棕榈酸酯或二季戊四醇六辛酸/癸酸酯;
醇类为十六醇、十八醇、二十二碳醇或十六十八醇。
所述的液体脂质为植物油脂、矿物油脂及合成油脂的一种或两种以上的组合;
其中植物油脂为霍霍巴油、澳洲坚果油、橄榄油、甜杏仁油、葡萄籽油、鳄梨油、米糠油、红花油、椰子油、蓖麻油、向日葵仔油、小麦胚芽油或者薰衣草油等;
矿物油脂为白油;
合成油脂为肉豆蔻酸异丙酯、异硬脂酸异丙酯、硬酯酸十三酯、硬脂酸甘油酯、异壬酸异壬酯、异构十六烷烃、棕榈酸异辛酯、棕榈酸异丙酯、辛酸/癸酸三甘油酯、肉豆蔻酸肉豆蔻酯、角鲨烷、油酸乙酯、硬脂酸十三酯或异硬脂酸异辛酯;
所述的无机盐为氯化钠、氯化钾或氯化钙;
所述的防腐剂为醇类、尼泊金酯类、杰马类、山梨酸、卡松、二羟甲基海因、1,2-苯并异噻唑啉-3-酮、苯甲酸甲酯、甲基异噻唑啉酮、三氯对称二苯脲、2-溴-2-硝基-1.3-丙二醇、甘油单月桂酸酯、重氮烷基脲、丙二醇-5-溴-5硝基-1,3-二惡烷、脱氢醋酸、丙二醇-5-溴-5硝基-1,3-二惡烷、丙二醇-双咪唑烷基脲、双咪唑烷基脲/羟苯甲酯/丙二醇、碘代丙炔基丁基甲氨酸酯中的一种或两种以上的组合;
其中,醇类为o-伞花烃-5-醇、聚季铵盐-73/戊二醇、戊二醇、丁间二醇、甲基丙二醇或苯氧乙醇;
尼泊金酯类尼泊金甲酯、尼泊金乙酯、尼泊金丙酯或尼泊金丁酯;
杰马类为咪唑烷基脲或双咪唑烷基脲。
上述的包覆维生素A棕榈酸酯的纳米固体脂质载体的制备方法,具体包括如下步骤:
(1)、将维生素A棕榈酸酯、磷脂、固体脂质、液体脂质、固态乳化剂加入到容器中,控制温度为70~85℃下熔融,并分散均匀,得到油相;
(2)、将无机盐和去离子水加入到另一容器中,加热到70~85℃,以800rpm速率均质,得到水相;
(3)、将步骤(1)所得的油相加入到步骤(2)均质的水相中,继续以800rpm的速率均质3~6min,得到乳化体系;
(4)、将步骤(3)所得乳化体系以80~800W的功率超声4~20min,然后以200~800r/min的速度边搅拌边冷却,温度降至40~60℃时,加入防腐剂并搅拌均匀,随后冷却到室温,即得包覆维生素A棕榈酸酯的纳米固体脂质载体。
本发明的有益效果
本发明的一种包覆维生素A棕榈酸酯的纳米固体脂质载体,由于维生素A棕榈酸酯被包覆于纳米固体脂质载体结构中,避免了光线的直接照射,因此提高了维生素A棕榈酸酯的稳定性;
进一步,本发明的一种包覆维生素A棕榈酸酯的纳米固体脂质载体,由于在该纳米固体脂质载体结构中含有磷脂,磷脂结构与皮肤脂质结构的相似性,提高了包覆维生素A棕榈酸酯纳米固体脂质载体结构在皮肤上的粘附性,因此,促进了维生素A棕榈酸酯的渗透性;
进一步,本发明的一种包覆维生素A棕榈酸酯的纳米固体脂质载体,由于维生素A棕榈酸酯被包覆于纳米固体脂质载体结构中,形成水悬浮液,有利于分散在水介质中,维生素A棕榈酸酯以分子结构存在于载体结构中;同时载体结构促进了活性成分的渗透,因此维生素A棕榈酸酯利用率高。
进一步,本发明的一种包覆维生素A棕榈酸酯的纳米固体脂质载体,由于采用了脂质体主原料磷脂应用于固体脂质载体结构中,在固体脂质载体结构优势的基础上,增加了脂质体与皮肤良好亲和性的特点,并避免了脂质体与固体脂质载体单一结构的缺点,如脂质体结构极易受到表面活性剂的破坏,以及固体脂质微粒载体因与皮肤亲和性不够等方面的不足,结合本发明的包覆维生素A棕榈酸酯的纳米固体脂质载体的制备方法,可以有效控制包覆维生素A棕榈酸酯的纳米固体脂质体的粒径在50~200nm,以更有利于其粘附于角质层,促进了活性成分维生素A棕榈酸酯在角质层上的渗透,从而提高了维生素A棕榈酸酯的利用率。
附图说明
图1、实施例6所得的包覆维生素A棕榈酸酯的纳米固体脂质载体的扫描电镜图。
具体实施方式
下面通过具体实例并结合附图对本发明做进一步描述,但本发明的保护范围并不仅限于此。
本发明的各实施例中所用的原料,如固体脂质、液体脂质、维生素A棕榈酸、磷脂、固态乳化剂及多元醇、无机盐等,除特殊说明的外,均为化妆品中常用原料,为市售。
本发明的实施例3所得的含磷脂的包覆维生素A棕榈酸酯的纳米固体脂质载体与实施例3的对照实施例所得的不含磷脂的包覆维生素A棕榈酸酯的纳米固体脂质载体进行维生素A棕榈酸酯渗透性数据测定方法如下:
1、所用仪器:Agilent1260高效液相色谱仪,HS-02水平透皮扩散渗透仪。
2、操作步骤:
(1)配置接收液:40%的PBS缓冲溶液+60%的无水乙醇。
(2)体外透皮扩散实验
①用2mL的移液管移取1mL待测实施例中所得的含磷脂的包覆维生素A棕榈酸酯的纳米固体脂质载体于10mL容量瓶中,用去离子水定容至10mL,摇晃均匀,即将原样品稀释为0.8%维生素A棕榈酸酯的纳米脂质载体,备用液1;同时移取2mL实施例3的对照实施例所得的不含磷脂的包覆维生素A棕榈酸酯的纳米固体脂质载体,做同样处理,用去离子水定容至10mL,摇匀,备用液2;
②在接收池内装入搅拌子,并装满接收液,将人造皮肤固定在扩散池的供给池和接收池之间(亮面朝供给池,暗面朝接收池),使皮肤浸入到溶液中;
③在供给池中装满(1)中的备用液1作为供给液,同时在另一个供给池中装满备用液2,作为供给液,同时对比两个样品的渗透性;
④保持循环水的温度为37℃,在一定的转速下,分别在1h、2h、4h、6h、8h、10h、12h、24h、36h时用1mL医用无菌注射器抽取1mL接收液,同时补充同体积新鲜接收液。样品经过0.22μm过滤膜过滤后,用高效液相测滤液中维生素A棕榈酸酯的浓度。
实验结果:
其中Cn:第n次取样时接收液中药物浓度,μg/mL;
V:接收室中接收液体积,7mL;
Ci:第i次取样时接收液中药物浓度,μg/mL;
1.0:每次取样体积,mL;
S:有效渗透面积,1cm2;
Q:渗透率,μg/cm2。
实施例1
一种包覆维生素A棕榈酸酯的纳米固体脂质载体,按100g的总量计算,其原料组成及含量如下:
所述的磷脂为PC含量为50%的大豆卵磷脂,北京美亚斯磷脂技术有限公司生产的食品级产品;
所述的固态乳化剂为鲸蜡硬脂醇聚醚-20;
所述的固体脂质为单硬脂酸甘油酯;
所述的液体脂质为澳洲坚果油;
所述的无机盐为氯化钠;
所述的防腐剂为重氮烷基脲。
上述包覆维生素A棕榈酸酯的纳米固体脂质载体,具体包括如下步骤:
(1)、将维生素A棕榈酸酯、磷脂、固体脂质、液体脂质、固态乳化剂加入到容器中,控制温度为70~85℃下熔融,并分散均匀,得到油相;
(2)、将无机盐和去离子水加入到另一容器中,加热到70~85℃,以800rpm速率均质,得到水相;
(3)、将步骤(1)所得的油相加入到步骤(2)均质的水相中,继续以800rpm的速率均质3~6min,得到乳化体系;
(4)、将步骤(3)所得乳化体系以80~800W的功率超声4~20min,然后以200~800r/min的速度边搅拌边冷却,温度降至40~60℃时,加入防腐剂并搅拌均匀,随后冷却到室温,即得包覆维生素A棕榈酸酯的纳米固体脂质载体。
实施例2
一种包覆维生素A棕榈酸酯的纳米固体脂质载体,按100g的总量计算,其原料组成及含量如下:
所述的磷脂为PC含量为70%的蛋黄卵磷脂,北京美亚斯磷脂技术有限公司生产的食品级产品;
所述的固态乳化剂为PEG-8双油酸酯;
所述的固体脂质为十六醇;
所述的液体脂质为硬酯酸十三酯;
所述的无机盐为氯化钾;
所述的防腐剂为尼泊金甲酯。
上述包覆维生素A棕榈酸酯的纳米固体脂质载体的制备方法,同实施例1。
实施例3
一种包覆维生素A棕榈酸酯的纳米固体脂质载体,即含磷脂的包覆维生素A棕榈酸酯的纳米固体脂质载体,按100g的总量计算,其原料组成及含量如下:
所述的磷脂为PC含量为70%的大豆卵磷脂,山西森弗天然制品有限公司生产的食品级产品;
所述的固态乳化剂为鲸蜡硬脂基葡糖苷;
所述的固体脂质为氢化蓖麻油;
所述的液体脂质为棕榈酸异丙酯;
所述的无机盐为氯化钾;
所述的防腐剂为丙二醇-双咪唑烷基脲。
上述包覆维生素A棕榈酸酯的纳米固体脂质载体,即含磷脂的包覆维生素A棕榈酸酯的纳米固体脂质载体的制备方法,同实施例1。
实施例3对照实例
一种包覆维生素A棕榈酸酯的纳米固体脂质载体,即不含磷脂的包覆维生素A棕榈酸酯的纳米固体脂质载体,按100g的总量计算,其原料组成及含量如下:
所述的固态乳化剂为鲸蜡硬脂基葡糖苷;
所述的固体脂质为氢化蓖麻油;
所述的液体脂质为棕榈酸异丙酯;
所述的无机盐为氯化钾;
所述的防腐剂为丙二醇-双咪唑烷基脲。
上述不含磷脂的包覆维生素A棕榈酸酯的纳米固体脂质载体的制备方法,具体包括如下步骤:
(1)、将维生素A棕榈酸酯、固体脂质、液体脂质、固态乳化剂加入到容器中,控制温度为70~85℃下熔融,并分散均匀,得到油相;
(2)、将无机盐和去离子水加入到另一容器中,加热到70~85℃,以800rpm速率均质,得到水相;
(3)、将步骤(1)所得的油相加入到步骤(2)均质的水相中,继续以800rpm的速率均质3~6min,得到乳化体系;
(4)、将步骤(3)所得乳化体系以80~800W的功率超声4~20min,然后以200~800r/min的速度边搅拌边冷却,温度降至40~60℃时,加入防腐剂并搅拌均匀,随后冷却到室温,得包覆维生素A棕榈酸酯的纳米固体脂质载体,即为不含磷脂的包覆维生素A棕榈酸酯的纳米固体脂质载体。
对上述实施例3所得的含磷脂的包覆维生素A棕榈酸酯的纳米固体脂质载体与实施例3的对照实施例所得的不含磷脂的包覆维生素A棕榈酸酯的纳米固体脂质载体中进行维生素A棕榈酸酯进行渗透性数据测定,结果见下表:
从上表中可以看出含磷脂的固体脂质载体结构包覆的维生素A棕榈酸酯在人造皮肤上的粘附量大于实施例3的对照实施例中所得的不含磷脂的固体脂质载体结构包覆维生素A棕榈酸酯的粘附量,高的粘附量有利于促进维生素A棕榈酸酯渗透于角质层中,由此表明了含磷脂的固体脂质载体结构包覆的维生素A棕榈酸酯更有利于在皮肤上的渗透。
实施例4
一种包覆维生素A棕榈酸酯的纳米固体脂质载体,按100g的总量计算,其原料组成及含量如下:
所述的磷脂为PC含量为80%的大豆卵磷脂,山西森弗天然制品有限公司生产的食品级产品;
所述的固态乳化剂为聚甘油-6双硬脂酸酯;
所述的固体脂质为二十二酸;
所述的液体脂质为小麦胚芽油;
所述的无机盐为氯化钙;
所述的防腐剂为2-溴-2-硝基-1.3-丙二醇。
上述的包覆维生素A棕榈酸酯的纳米固体脂质载体的制备方法,同实施例1。
实施例5
一种包覆维生素A棕榈酸酯的纳米固体脂质载体,按100g的总量计算,其原料组成及含量如下:
所述的磷脂为PC含量为90%的大豆卵磷脂,山西森弗天然制品有限公司生产的医药级产品;
所述的固态乳化剂为蔗糖酯;
所述的固体脂质为棕榈酸;
所述的液体脂质为肉豆蔻酸异丙酯;
所述的无机盐为氯化钙;
所述的防腐剂为尼泊金甲酯。
上述的包覆维生素A棕榈酸酯的纳米固体脂质载体的制备方法,同实施例1。
实施例6
一种包覆维生素A棕榈酸酯的纳米固体脂质载体,按100g的总量计算,其原料组成及含量如下:
所述的磷脂为PC含量为95%的氢化卵磷脂,上海一基生物科技有限公司提供的医药级产品;
所述的固态乳化剂为双子星乳化剂;
所述的固体脂质为二季戊四醇六辛酸/癸酸酯;
所述的液体脂质为辛酸/癸酸三甘油酯;
所述的无机盐为氯化钠;
所述的防腐剂为双咪唑烷基脲。
上述的包覆维生素A棕榈酸酯的纳米固体脂质载体的制备方法,同实施例1。
运用Quanta200F型扫描电镜(FEIcompany,Quanta200FEG,Holland,加速电压5~30kv)对上述所得的包覆维生素A棕榈酸酯的纳米固体脂质载体的外貌形态进行扫描,所得的微观形貌图如图1所示。从图1中可以看出纳米固体脂质微粒排列紧密,颗粒均匀,对维生素A棕榈酸酯具有很好的包覆作用。
综上所述,本发明的一种包覆维生素A棕榈酸酯的纳米固体脂质载体,因在载体结构中引入磷脂,提高了载体结构在皮肤上的粘附性,进而有利于维生素A棕榈酸酯在皮肤上的渗透。
以上所述仅是本发明的实施方式的举例,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明技术原理的前提下,还可以做出若干改进和变型,这些改进和变型也应视为本发明的保护范围。
Claims (9)
1.一种包覆维生素A棕榈酸酯的纳米固体脂质载体,其特征在于所述的包覆维生素A棕榈酸酯的纳米固体脂质载体按重量百分比计算,其原料组成及含量如下:
所述的磷脂为磷脂酰胆碱含量为50%~95%的大豆卵磷脂、蛋黄卵磷脂、氢化卵磷脂及脱油磷脂中的一种或两种以上的组合;
所述的固态乳化剂为鲸蜡硬脂醇聚醚类、PEG酯类、葡糖苷类、聚甘油-3甲基葡糖二硬脂酸酯、硬酯酰谷氨酸钠、双子星乳化剂或聚甘油-6双硬脂酸酯;
其中硬脂醇聚醚类为鲸蜡硬脂醇聚醚-25、鲸蜡硬脂醇聚醚-6、鲸蜡硬脂醇聚醚-12、鲸蜡硬脂醇聚醚-20、鲸蜡硬脂醇聚醚-30、硬脂醇聚醚-2、硬脂醇聚醚-21或三鲸蜡硬酯醇醚-4磷酸;
PEG酯类为PEG-20三山嵛酸甘油酯、PEG-8双油酸酯、PEG-8双硬脂酸酯、PEG-4月桂酸酯、PEG-8油酸酯、PEG-8硬脂酸酯、PEG-8蜂蜡、PEG-20硬脂酸酯或PEG-32硬脂酸酯、PEG-40氢化蓖麻油、PEG-20十八醇醚、PEG-15十六十八醇醚、PEG-2十六醇醚、PEG-10十六醇醚或PEG-4月桂酸酯;
葡糖苷类为鲸蜡硬脂基葡糖苷、羟基硬脂醇与羟基硬脂糖苷、蔗糖酯、花生醇葡糖苷、山嵛醇葡糖苷、鲸蜡硬脂基葡糖苷、鲸蜡硬脂醇葡糖苷、椰油基葡糖苷、PEG-20甲基葡萄糖苷倍半硬脂酸酯或甲基葡萄糖苷倍半硬脂酸酯;
所述的固体脂质为饱和脂肪酸类、类固醇类、甘油酯类、蜡质类、醇类、氢化蓖麻油、鲸蜡硬酯醇、硬酯醇或季戊四醇二硬脂酸酯;
其中饱和脂肪酸类为硬脂酸、棕榈酸、癸酸或二十二酸类固醇类为胆固醇;
甘油酯类为硬脂酸甘油酯、鲸蜡硬酯醇辛酸酯、单硬脂酸甘油酯、棕榈酸鲸蜡酯、三硬脂酸甘油酯或三月桂酸甘油酯;
蜡质类为季戊四醇四山俞酸酯、季戊四醇四辛酸/癸酸酯、季戊四醇四油酸酯、季戊四醇四硬脂酸酯、肉豆蔻酸十四烷酯、乳酸鲸蜡酯、蓖麻油酸鲸蜡酯、肉豆蔻酸肉豆蔻酯、棕榈酸十六酯、十八酸十八酯、鲸蜡醇棕榈酸酯或二季戊四醇六辛酸/癸酸酯;
醇类为十六醇、十八醇、二十二碳醇或十六十八醇。
所述的液体脂质为植物油脂、矿物油脂及合成油脂的一种或两种以上的组合;
其中植物油脂为霍霍巴油、澳洲坚果油、橄榄油、甜杏仁油、葡萄籽油、鳄梨油、米糠油、红花油、椰子油、蓖麻油、向日葵仔油、小麦胚芽油或者薰衣草油等;
矿物油脂为白油;
合成油脂为肉豆蔻酸异丙酯、异硬脂酸异丙酯、硬酯酸十三酯、硬脂酸甘油酯、异壬酸异壬酯、异构十六烷烃、棕榈酸异辛酯、棕榈酸异丙酯、辛酸/癸酸三甘油酯、肉豆蔻酸肉豆蔻酯、角鲨烷、油酸乙酯、硬脂酸十三酯或异硬脂酸异辛酯;
所述的无机盐为氯化钠、氯化钾或氯化钙;
所述的防腐剂为醇类、尼泊金酯类、杰马类、山梨酸、卡松、二羟甲基海因、1,2-苯并异噻唑啉-3-酮、苯甲酸甲酯、甲基异噻唑啉酮、三氯对称二苯脲、2-溴-2-硝基-1.3-丙二醇、甘油单月桂酸酯、重氮烷基脲、丙二醇-5-溴-5硝基-1,3-二惡烷、脱氢醋酸、丙二醇-5-溴-5硝基-1,3-二惡烷、丙二醇-双咪唑烷基脲、双咪唑烷基脲/羟苯甲酯/丙二醇、碘代丙炔基丁基甲氨酸酯中的一种或两种以上的组合;
其中,所述的醇类为o-伞花烃-5-醇、聚季铵盐-73/戊二醇、戊二醇、丁间二醇、甲基丙二醇或苯氧乙醇;
所述的尼泊金酯类尼泊金甲酯、尼泊金乙酯、尼泊金丙酯或尼泊金丁酯;
杰马类为咪唑烷基脲或双咪唑烷基脲。
2.如权利要求1所述的一种包覆维生素A棕榈酸酯的纳米固体脂质载体,其特征在于:
所述的磷脂为磷脂酰胆碱含量为50%-90%的大豆卵磷脂、磷脂酰胆碱含量为70%的蛋黄卵磷脂或磷脂酰胆碱含量为95%的氢化卵磷脂;
所述的固态乳化剂为鲸蜡硬脂醇聚醚类、PEG酯类、葡糖苷类、双子星乳化剂或聚甘油-6双硬脂酸酯;
其中硬脂醇聚醚类为鲸蜡硬脂醇聚醚-20;
PEG酯类为PEG-8双油酸酯;
葡糖苷类为鲸蜡硬脂基葡糖苷或蔗糖酯;
所述的固体脂质为饱和脂肪酸类、甘油酯类、蜡质类、醇类或氢化蓖麻油;
其中饱和脂肪酸类为棕榈酸或二十二酸;
甘油酯类为单硬脂酸甘油酯;
蜡质类为二季戊四醇六辛酸/癸酸酯;
醇类为十六醇;
所述的液体脂质为植物油脂或者合成油脂;
其中植物油脂为澳洲坚果油或小麦胚芽油;
合成油脂为肉豆蔻酸异丙酯、硬酯酸十三酯、棕榈酸异丙酯或辛酸/癸酸三甘油酯;
所述的防腐剂为尼泊金酯类、杰马类、2-溴-2-硝基-1.3-丙二醇、重氮烷基脲或丙二醇-双咪唑烷基脲;
其中尼泊金酯类为尼泊金甲酯;
杰马类为双咪唑烷基脲。
3.如权利要求2所述的一种包覆维生素A棕榈酸酯的纳米固体脂质载体,其特征在于按重量百分比计算,其原料组成及含量如下:
所述的磷脂为磷脂酰胆碱含量为50%的大豆卵磷脂;
所述的固态乳化剂为鲸蜡硬脂醇聚醚-20;
所述的固体脂质为单硬脂酸甘油酯;
所述的液体脂质为澳洲坚果油;
所述的无机盐为氯化钠;
所述的防腐剂为重氮烷基脲。
4.如权利要求2所述的一种包覆维生素A棕榈酸酯的纳米固体脂质载体,其特征在于按重量百分比计算,其原料组成及含量如下:
所述的磷脂为磷脂酰胆碱含量为70%的蛋黄卵磷脂;
所述的固态乳化剂为PEG-8双油酸酯;
所述的固体脂质为十六醇;
所述的液体脂质为硬酯酸十三酯;
所述的无机盐为氯化钾;
所述的防腐剂为尼泊金甲酯。
5.如权利要求2所述的一种包覆维生素A棕榈酸酯的纳米固体脂质载体,其特征在于按重量百分比计算,其原料组成及含量如下:
所述的磷脂为磷脂酰胆碱含量为70%的大豆卵磷脂;
所述的固态乳化剂为鲸蜡硬脂基葡糖苷;
所述的固体脂质为氢化蓖麻油;
所述的液体脂质为棕榈酸异丙酯;
所述的无机盐为氯化钾;
所述的防腐剂为丙二醇-双咪唑烷基脲。
6.如权利要求2所述的一种包覆维生素A棕榈酸酯的纳米固体脂质载体,其特征在于按重量百分比计算,其原料组成及含量如下:
所述的磷脂为磷脂酰胆碱含量为80%的大豆卵磷脂;
所述的固态乳化剂为聚甘油-6双硬脂酸酯;
所述的固体脂质为二十二酸;
所述的液体脂质为小麦胚芽油;
所述的无机盐为氯化钙;
所述的防腐剂为2-溴-2-硝基-1.3-丙二醇。
7.如权利要求2所述的一种包覆维生素A棕榈酸酯的纳米固体脂质载体,其特征在于按重量百分比计算,其原料组成及含量如下:
所述的磷脂为磷脂酰胆碱含量为90%的大豆卵磷脂;
所述的固态乳化剂为蔗糖酯;
所述的固体脂质为棕榈酸;
所述的液体脂质为肉豆蔻酸异丙酯;
所述的无机盐为氯化钙;
所述的防腐剂为尼泊金甲酯。
8.如权利要求2所述的一种包覆维生素A棕榈酸酯的纳米固体脂质载体,其特征在于按重量百分比计算,其原料组成及含量如下:
所述的磷脂为磷脂酰胆碱含量为95%的氢化卵磷脂;
所述的固态乳化剂为双子星乳化剂;
所述的固体脂质为二季戊四醇六辛酸/癸酸酯;
所述的液体脂质为辛酸/癸酸三甘油酯;
所述的无机盐为氯化钠;
所述的防腐剂为双咪唑烷基脲。
9.如权利要求1-8任一所述的一种包覆维生素A棕榈酸酯的纳米固体脂质载体的制备方法,其特征在于具体包括如下步骤:
(1)、将维生素A棕榈酸酯、磷脂、固体脂质、液体脂质、固态乳化剂加入到容器中,控制温度为70~85℃下熔融,并分散均匀,得到油相;
(2)、将无机盐和去离子水加入到另一容器中,加热到70~85℃,以800rpm速率均质,得到水相;
(3)、将步骤(1)所得的油相加入到步骤(2)均质的水相中,继续以800rpm的速率均质3~6min,得到乳化体系;
(4)、将步骤(3)所得乳化体系以80~800W的功率超声4~20min,然后以200~800r/min的速度边搅拌边冷却,温度降至40~60℃时,加入防腐剂并搅拌均匀,随后冷却到室温,即得包覆维生素A棕榈酸酯的纳米固体脂质载体。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610033759.9A CN105496801A (zh) | 2016-01-19 | 2016-01-19 | 一种包覆维生素a棕榈酸酯的纳米固体脂质载体及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610033759.9A CN105496801A (zh) | 2016-01-19 | 2016-01-19 | 一种包覆维生素a棕榈酸酯的纳米固体脂质载体及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105496801A true CN105496801A (zh) | 2016-04-20 |
Family
ID=55705369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610033759.9A Pending CN105496801A (zh) | 2016-01-19 | 2016-01-19 | 一种包覆维生素a棕榈酸酯的纳米固体脂质载体及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105496801A (zh) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107549801A (zh) * | 2017-08-24 | 2018-01-09 | 福格森(武汉)生物科技股份有限公司 | 一种多层包埋固体脂质钙微粒 |
| CN108451787A (zh) * | 2018-05-23 | 2018-08-28 | 上海格兰化妆品有限公司 | 一种包埋维生素a醇的纳米脂质载体及其制备方法 |
| US10493009B2 (en) | 2016-12-13 | 2019-12-03 | The Procter & Gamble Company | Stable personal care compositions containing a retinoid |
| CN113164368A (zh) * | 2018-12-04 | 2021-07-23 | 株式会社Lg生活健康 | 高含量和缓释型类维生素a胶囊以及包含其的皱纹改善用组合物 |
| CN114948778A (zh) * | 2021-02-18 | 2022-08-30 | 株式会社爱茉莉太平洋 | 包含转运体的难溶性功效物质传递体 |
| CN117137824A (zh) * | 2023-08-14 | 2023-12-01 | 诺斯贝尔化妆品股份有限公司 | 含有视黄醇棕榈酸酯的抗衰组合物及其制备方法和用途 |
| EP4282281A3 (en) * | 2019-12-04 | 2024-03-06 | Alesco S.r.l. | Solid form formulation comprising chromium or copper or a vitamin, compositions and uses thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008058755A1 (en) * | 2006-11-17 | 2008-05-22 | Abbott Gmbh & Co. Kg | Nanocrystals for use in topical cosmetic formulations and method of production thereof |
| CN104127326A (zh) * | 2014-07-10 | 2014-11-05 | 上海应用技术学院 | 一种包覆Vc棕榈酸酯的纳米固体脂质载体及其制备方法 |
-
2016
- 2016-01-19 CN CN201610033759.9A patent/CN105496801A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008058755A1 (en) * | 2006-11-17 | 2008-05-22 | Abbott Gmbh & Co. Kg | Nanocrystals for use in topical cosmetic formulations and method of production thereof |
| CN104127326A (zh) * | 2014-07-10 | 2014-11-05 | 上海应用技术学院 | 一种包覆Vc棕榈酸酯的纳米固体脂质载体及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 孔荣: "维生素A棕榈酸酯脂质纳米粒的制备及评价", 《万方数据》 * |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10493009B2 (en) | 2016-12-13 | 2019-12-03 | The Procter & Gamble Company | Stable personal care compositions containing a retinoid |
| CN107549801A (zh) * | 2017-08-24 | 2018-01-09 | 福格森(武汉)生物科技股份有限公司 | 一种多层包埋固体脂质钙微粒 |
| CN107549801B (zh) * | 2017-08-24 | 2020-11-13 | 福格森(武汉)生物科技股份有限公司 | 一种多层包埋固体脂质钙微粒 |
| CN108451787A (zh) * | 2018-05-23 | 2018-08-28 | 上海格兰化妆品有限公司 | 一种包埋维生素a醇的纳米脂质载体及其制备方法 |
| CN108451787B (zh) * | 2018-05-23 | 2020-01-07 | 上海格兰化妆品有限公司 | 一种包埋维生素a醇的纳米脂质载体及其制备方法 |
| CN113164368A (zh) * | 2018-12-04 | 2021-07-23 | 株式会社Lg生活健康 | 高含量和缓释型类维生素a胶囊以及包含其的皱纹改善用组合物 |
| US12390402B2 (en) | 2018-12-04 | 2025-08-19 | Lg Household & Healthcare Ltd. | High-content and sustained-release retinoid capsule, and composition for reducing wrinkles, containing same |
| EP4282281A3 (en) * | 2019-12-04 | 2024-03-06 | Alesco S.r.l. | Solid form formulation comprising chromium or copper or a vitamin, compositions and uses thereof |
| CN114948778A (zh) * | 2021-02-18 | 2022-08-30 | 株式会社爱茉莉太平洋 | 包含转运体的难溶性功效物质传递体 |
| CN117137824A (zh) * | 2023-08-14 | 2023-12-01 | 诺斯贝尔化妆品股份有限公司 | 含有视黄醇棕榈酸酯的抗衰组合物及其制备方法和用途 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105534724A (zh) | 一种包覆白藜芦醇的纳米固体脂质载体及其制备方法 | |
| CN105496801A (zh) | 一种包覆维生素a棕榈酸酯的纳米固体脂质载体及其制备方法 | |
| Clares et al. | Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: Effect on skin permeation | |
| Lasoń et al. | Influence of process parameters on properties of Nanostructured Lipid Carriers (NLC) formulation. | |
| CN105496802A (zh) | 一种包覆维生素e醋酸酯的纳米固体脂质载体及其制备方法 | |
| CN106691888B (zh) | 一种高皮肤滞留光甘草定纳米组合物及其制备方法和用途 | |
| CN114392198A (zh) | 一种化妆品组合物及其制备方法 | |
| CN105232342B (zh) | 一种含多重结构的固体脂质载体及其制备方法 | |
| CN106420610A (zh) | 一种离子液体微乳及其应用 | |
| KR100949848B1 (ko) | 비타민c 유도체 함유 나노유화 화장료 조성물 및 그의제조방법 | |
| JP3867123B2 (ja) | アゼライン酸を含む組成物 | |
| CN104116643A (zh) | 一种包覆曲酸双棕榈酸酯的纳米固体脂质载体及制备方法 | |
| NO175040B (no) | Fremgangsmåte for fremstilling av et preparat for intravenös administrering av 3 | |
| CN103284950B (zh) | 皮脂脂质体及其制备方法 | |
| CN104127326A (zh) | 一种包覆Vc棕榈酸酯的纳米固体脂质载体及其制备方法 | |
| KR102813285B1 (ko) | 바쿠치올이 봉입된 NLC(Nanostructured Lipid Carriers)를 유효성분으로 함유하는 화장료 조성물 | |
| CN111603395B (zh) | 一种含有层状液晶的美白保湿乳液及其制备方法 | |
| CN115177537A (zh) | 一种基于珍珠粉稳定的皮克林乳液及其制备方法 | |
| Anitha et al. | Ethosomes-A noninvasive vesicular carrier for transdermal drug delivery | |
| CN110448525A (zh) | 一种预防脱发和促生发的外用非那雄胺脂质纳米制剂及其制备方法 | |
| CN100393300C (zh) | 含有脂溶性维生素c和二棕榈羟基脯氨酸的纳米粒子及其化妆品组成物 | |
| Moner et al. | A lamellar body mimetic system for the treatment of oxazolone-induced atopic dermatitis in hairless mice | |
| EP3568123A1 (de) | Einbringen von schwer und/oder nicht wasserlöslichen wirkstoffen mittels auf lipiden basierenden nanopartikeln/vesikeln in ein hydrophiles aus cellulose bestehendes dreidimensionales netzwerk | |
| CN104706575A (zh) | 一种氟比洛芬酯脂肪乳浓缩液、其制备方法及用途 | |
| CA2238263A1 (en) | Cortisone spray for topical administration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160420 |